Viking Therapeutics Financial Overview
Viking Therapeutics's market cap is currently $3.40B. The company's EPS TTM is €-0.6915812400000001; its P/E ratio is -15.19; Viking Therapeutics is scheduled to report earnings on October 22, 2025, and the estimated EPS forecast is €-0.77. See an overview of income statement, balance sheet, and cash flow financials.
